Open AccessCOMPARATIVE PHARMACOGNOSTIC EVALUATION OF MARKET SAMPLES OF PRSNIPARNI WITH GENUINE SOURCE OF URARIA PICTA (JACQ) DESV EX DC
Author(s) -
M Surabhi,
K N Anuradha
Publication year - 2021
Publication title -
epra international journal of research and development
Language(s) - English
Resource type - Journals
ISSN - 2455-7838
DOI - 10.36713/epra8828
Subject(s) - medicinal plants , phytochemical , raw material , population , traditional medicine , biology , habitat , toxicology , botany , medicine , ecology , environmental health
The medicinal plants and its active principles are playing a dominant role in the maintenance of human health since ancient times. The degree of threat to natural population of medicinal plants has increased, because more than 90% of medicinal plant raw material for herbal industries in India draw from natural habitat In ayurvedic medicine Dasamula plants are top traded group and their annual demand is more than1000 Metric tons, Prsniparni moola is one among the Dasamula, The degree of threat to natural population of medicinal plants has increased, because more than 90% of medicinal plant raw material for herbal industries in India draws from natural habitat, this demand is not often met with supply of original raw drugs alone and is topped up with other species of plants that are substitutes or adulterants. This directly affects the quality and efficacy of the herbal products and the same has reflected in case of Uraria picta. Over usage, destructive harvesting and lack of cultivation have reduced the availability of Uraria picta. Inorder to characterize and compare the raw drugs used as prsniparni in market, the candidate species traded under the name Prsniparni were subjected to macroscopic and organoleptic evaluation, microscopic study, Physical and Phytochemical evaluation.